Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BBSRC to fund new veterinary vaccinology network
New, exotic and re-emerging diseases have highlighted the need to re-think the current methods for developing vaccines.
New network will help tackle threat of animal diseases, including those spreading to humans.

The Biotechnology and Biological Sciences Research Council (BBSRC) is funding a new network of veterinary vaccinology experts to help in the fight against animal diseases - some of which have the potential to spread to humans.

The UK Veterinary Vaccinology Network (VVN) will bring together major UK researchers to enhance the uptake of new technologies in order to design, develop and deliver safe and effective vaccines for the next-generation.

Vaccines are a cost-effective way of preventing and eradicating disease. They are also an important tool in the war against infectious diseases.  With around 60 per cent of animal diseases having the potential to cause human infections, vaccines protect public health as well as enhance animal welfare.

While many vaccination campaigns have been successful - such as the eradication of rinderpest - the BBSRC say that new, exotic and re-emerging diseases have highlighted the need to re-think the current methods for developing vaccines.

Building on the UK strength in veterinary science, advances in biotechnology, and the biological revolution new technologies, the BBSRC say that there are opportunities for researchers to create new veterinary vaccines and increase efficient development pathways for them.

Network co-ordinator, Dr Bryan Charleston, said : "There is huge potential to improve animal welfare, human health, and the economic performance of the UK livestock industries by developing new vaccines for widespread infectious diseases caused by parasites, bacteria and viruses. The network will facilitate and promote coordination of research in this important field to generate the scientific knowledge and discoveries needed for a step change in veterinary vaccinology."

With the livestock industry estimated to have an annual value of over £14 billion in 2013, the BBSRC say that the research will have direct benefits for the UK economy.

The network includes experts from the AHVLA, Cambridge Veterinary School, Edinburgh University, Global Alliance for Livestock Veterinary Medicines, London School of Hygiene and Tropical Medicine, Moredun Research Institute, Oxford University, The Pirbright Institute, The Roslin Institute, The Royal Veterinary College and the University of Stirling.  

The network has funding for five years. The researchers will report to BBSRC and provide input into developing the future research agenda.

For more information visit www.bbsrc.ac.uk

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.